C. F. Andrade, H. Kaneda, S. Der, M. Tsang, M. Lodyga et al., Toll-like receptor and cytokine gene expression in the early phase of human lung transplantation, J Heart Lung Transplant, vol.25, pp.1317-1323, 2006.

D. Anglade, M. Corboz, A. Menaouar, J. C. Parker, S. Sanou et al., Blood flow vs. venous pressure effects on filtration coefficient in oleic acidinjured lung, J Appl Physiol, vol.84, pp.1011-1023, 1998.

P. F. Baconnier, A. Eberhard, and F. A. Grimbert, Theoretical analysis of occlusion techniques for measuring pulmonary capillary pressure, J Appl Physiol, vol.73, pp.1351-1359, 1992.

S. Brimioulle, V. Julien, R. Gust, J. K. Kozlowski, R. Naeije et al., Importance of hypoxic vasoconstriction in maintaining oxygenation during acute lung injury, Crit Care Med, vol.30, pp.874-880, 2002.

R. Briot, S. Bayat, D. Anglade, J. L. Martiel, and F. Grimbert, Monitoring the capillary-alveolar leakage in an A.R.D.S. model using broncho-alveolar lavage, Microcirculation, vol.15, pp.237-249, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00338172

R. Briot, S. Bayat, D. Anglade, J. L. Martiel, and F. Grimbert, Increased cardiac index due to terbutaline treatment aggravates capillaryalveolar macromolecular leakage in oleic acid lung injury in dogs, Crit Care, vol.13, p.166, 2009.

R. Briot, J. A. Frank, T. Uchida, J. W. Lee, C. S. Calfee et al., Elevated levels of the receptor for advanced glycation end products, a marker of alveolar epithelial type I cell injury, predict impaired alveolar fluid clearance in isolated perfused human lungs, Chest, vol.135, pp.269-275, 2009.

G. J. Burckart, R. Venkataramanan, R. J. Ptachcinski, T. E. Starzl, J. C. Gartner et al., Cyclosporine absorption following orthotopic liver transplantation, J Clin Pharmacol, vol.26, pp.647-651, 1986.
DOI : 10.1002/j.1552-4604.1986.tb02966.x
URL : http://europepmc.org/articles/pmc2964133?pdf=render

C. S. Calfee, L. B. Ware, M. D. Eisner, P. E. Parsons, B. T. Thompson et al., Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury, Thorax, vol.63, pp.1083-1089, 2008.

H. T. Chen, C. X. Yang, H. Li, C. J. Zhang, X. J. Wen et al., Cardioprotection of sevoflurane postconditioning by activating extracellular signal-regulated kinase 1/2 in isolated rat hearts, Acta Pharmacol Sin, vol.29, pp.931-941, 2008.

J. D. Christie, J. S. Sager, S. E. Kimmel, V. N. Ahya, C. Gaughan et al., Impact of primary graft failure on outcomes following lung transplantation, Chest, vol.127, pp.161-165, 2005.

M. Cypel, J. C. Yeung, M. Liu, M. Anraku, F. Chen et al., Normothermic ex vivo lung perfusion in clinical lung transplantation, N Engl J Med, vol.364, pp.1431-1440, 2012.

M. De-perrot, M. Liu, T. K. Waddell, and S. Keshavjee, State of the art. Ischemia reperfusioninduced-injury, Am J Respir Crit Care Med, vol.167, pp.490-511, 2003.

D. Hengst, W. A. Gielis, J. F. Lin, J. Y. , V. Schil et al., Lung ischemiareperfusion injury: a molecular and clinical view on a complex pathophysiological process, Am J Physiol Heart Circ Physiol, vol.299, pp.1283-1299, 2010.

A. S. Farivar, B. C. Mackinnon-patterson, A. D. Barnes, A. S. Mccourtie, and M. S. Mulligan, Cyclosporine modulates the response to hypoxia-reoxygenation in pulmonary artery endothelial cells, Ann Thorac Surg, vol.79, pp.1010-1016, 2005.

M. R. First, J. F. Neylan, L. L. Rocher, and A. Tejani, Hypertension after renal transplantation, J Am Soc Nephrol, vol.4, pp.30-36, 1994.

J. A. Frank, R. Briot, J. W. Lee, A. Ishizaka, T. Uchida et al., Physiological and biochemical markers of alveolar epithelial barrier dysfunction in perfused human lungs, Am J Physiol Lung Cell Mol Physiol, vol.293, pp.52-59, 2007.

J. Gerlach, A. Jorres, R. Nohr, K. Zeilinger, G. Spatkowski et al., Local liberation of cytokines during liver preservation, Transpl Int, vol.12, pp.261-265, 1999.

L. Gomez, H. Thibault, A. Gharib, J. M. Dumont, G. Vuagniaux et al., Inhibition of mitochondrial permeability transition improves functional recovery and reduces mortality following acute myocardial infarction in mice, Am J Physiol Heart Circ Physiol, vol.293, pp.1654-1661, 2007.

E. J. Griffiths and A. P. Halestrap, Protection by Cyclosporin A of ischemia/reperfusioninduced damage in isolated rat hearts, J Mol Cell Cardiol, vol.25, pp.1461-1469, 1993.

, International Society for Heart and Lung Transplantation. Annual report, 2010.

M. Jabaudon, E. Futier, L. Roszyk, E. Chalus, R. Guerin et al., Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients, Crit Care Med, vol.39, pp.480-488, 2011.

N. Kanaya, I. Kobayashi, M. Nakayama, S. Fujita, and A. Namiki, ATP sparing effect of isoflurane during ischaemia and reperfusion of the canine heart, Br J Anaesth, vol.74, pp.563-568, 1995.

N. Koulmann, V. Novel-chate, A. Peinnequin, R. Chapot, B. Serrurier et al., Cyclosporin A inhibits hypoxia-induced pulmonary hypertension and right ventricle hypertrophy, Am J Respir Crit Care Med, vol.174, pp.699-705, 2006.
URL : https://hal.archives-ouvertes.fr/inserm-00410546

B. Krishnadasan, B. V. Naidu, M. Rosengart, A. L. Farr, A. Barnes et al., Decreased lung ischemia-reperfusion injury in rats after preoperative administration of cyclosporine and tacrolimus, J Thorac Cardiovasc Surg, vol.123, pp.756-767, 2002.

Y. H. Lee, K. H. Park, and Y. S. Ku, Pharmacokinetic changes of cyclosporine after intravenous and oral administration to rats with uranyl nitrate-induced acute renal failure, Int J Pharm, vol.194, pp.221-227, 2000.

S. Lemay, H. Rabb, G. Postler, and A. K. Singh, Prominent and sustained up-regulation of gp130-signaling cytokines and the chemokine MIP-2 in murine renal ischemia-reperfusion injury, Transplantation, vol.69, pp.959-963, 2000.

S. W. Lim, C. Li, and K. O. Ahn, Cyclosporineinduced renal injury induces toll-like receptor and maturation of dendritic cells, Transplantation, vol.80, pp.691-699, 2005.

R. J. Morrison, H. D. Short, G. P. Noon, and A. E. Frost, Hypertension after lung transplantation, J Heart Lung Transplant, vol.12, pp.928-931, 1993.

B. V. Naidu, B. Krishnadasan, K. Byrne, A. L. Farr, M. Rosengart et al., Regulation of chemokine expression by Cyclosporine A in alveolar macrophages exposed to hypoxia and reoxygenation

, Ann Thorac Surg, vol.74, pp.899-905, 2002.

D. Obal, S. Dettwiler, C. Favoccia, H. Scharbatke, B. Preckel et al., The influence of mitochondrial KATP-channels in the cardioprotection of preconditioning and postconditioning by sevoflurane in the rat in vivo, Anesth Analg, vol.101, pp.1252-1260, 2005.

T. Oto, A. P. Griffiths, B. J. Levvey, D. V. Pilcher, T. J. Williams et al., Definitions of primary graft dysfunction after lung transplantation: Cyclosporine in Ex Vivo Pig Lungs

J. Wiley and &. , Sons Ltd differences between bilateral and single lung transplantation, J Thorac Cardiovasc Surg, vol.132, pp.140-147, 2006.

C. Piot, P. Croisille, P. Staat, H. Thibault, G. Rioufol et al., Effect of cyclosporine on reperfusion injury in acute myocardial infarction, N Engl J Med, vol.359, pp.473-481, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00428144

B. Preckel, W. Schlack, T. Comf-ere, D. Obal, and H. Barthel, Th? amer V. Effects of enflurane, isoflurane, sevoflurane and desflurane on reperfusion injury after regional myocardial ischemia in the rabbit heart in vivo, Br J Anesth, vol.81, pp.905-912, 1998.

M. Redondo-horcajo, N. Romero, M. , P. , M. Inez-ruiz et al., Cyclosporine A-induced nitration of tyrosine 34 MnSOD in endothelial cells: role of mitochondrial superoxide, Cardiovasc Res, vol.87, pp.356-365, 2010.

P. G. Sanchez, G. J. Bittle, L. Burdorf, R. N. Pierson, and B. P. Griffith, State of art: clinical ex vivo lung perfusion: rationale, current status, and future directions, J Heart Lung Transplant, vol.31, pp.339-348, 2012.

M. Sander, T. Lyson, G. D. Thomas, and R. G. Victor, Sympathetic neural mechanisms of cyclosporine-induced hypertension, Am J Hypertens, vol.9, pp.121-138, 1996.

U. Scherrer, S. F. Vissing, B. J. Morgan, J. A. Rollins, R. S. Tindall et al., Cyclosporine-induced sympathetic activation and hypertension after heart transplantation, N Engl J Med, vol.323, pp.693-699, 1990.

C. Serrick, R. Adoumie, A. Giaid, and H. Shennib, The early release of interleukin-2, tumor necrosis factor-alpha and interferongamma after ischemia reperfusion injury in the lung allograft, Transplantation, vol.58, pp.1158-1162, 1994.

Y. Shargall, G. Guenther, V. N. Ahya, A. Ardehali, and A. Singhal, Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part VI: treatment, J Heart Lung Transplant, vol.24, pp.1489-1500, 2005.

P. M. Soccal, Y. Gasche, D. N. Miniati, G. Hoyt, G. J. Berry et al., Matrix metalloproteinase inhibition decreases ischemia-reperfusion injury after lung transplantation, Am J Transplant, vol.4, pp.41-50, 2004.

E. H. Starling, On the absorption of fluids from the connective tissue spaces, J Physiol, vol.19, pp.312-326, 1896.

S. Steen, Q. Liao, P. N. Wierup, R. Bolys, and L. Pierre, Sj? oberg T. Transplantation of lungs from non-heart-beating donors after functional assessment ex vivo, Ann Thorac Surg, vol.76, pp.244-252, 2003.

I. L. Theissen and A. Meissner, Hypoxic pulmonary vasoconstriction, Anaesthesist, vol.45, pp.643-652, 1996.

D. L. Travis, R. Fabia, G. G. Netto, B. S. Husberg, R. M. Goldstein et al., Protection by Cyclosporine A against normothermic liver ischemia-reperfusion in pigs, J Surg Res, vol.75, pp.116-126, 1998.

T. Uchida, M. Shirasawa, L. B. Ware, K. Kojima, Y. Hata et al., Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury, Am J Respir Crit Care Med, vol.173, pp.1008-1015, 2006.

G. Van-assche, D. 'haens, G. Noman, M. Vermeire, S. Hiele et al., Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis, Gastroenterology, vol.125, pp.1025-1031, 2003.

L. B. Ware and M. A. Matthay, The acute respiratory distress syndrome, N Engl J Med, vol.342, pp.1334-1349, 2000.

M. Winkler, C. Brinkmann, U. Jost, K. Oldhafer, B. Ringe et al., Long-term side effects of cyclosporine-based immunosuppression in patients after liver transplantation, Transplant Proc, vol.26, pp.2679-2682, 1994.

C. W. Yang, H. J. Ahn, H. J. Han, W. Y. Kim, C. Li et al., Pharmacological preconditioning with low-dose cyclosporine or FK506 reduces subsequent ischemia/reperfusion injury in rat kidney, Transplantation, vol.72, pp.1753-1759, 2001.